MDPI and ACS Style
Tomita, N.; Saito, S.; Terada-Hirashima, J.; Mikami, A.; Uemura, Y.; Kutsuna, S.; Nomoto, H.; Fujisawa, K.; Nagashima, M.; Terada, M.;
et al. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). Life 2022, 12, 856.
https://doi.org/10.3390/life12060856
AMA Style
Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M,
et al. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). Life. 2022; 12(6):856.
https://doi.org/10.3390/life12060856
Chicago/Turabian Style
Tomita, Noriko, Sho Saito, Junko Terada-Hirashima, Ayako Mikami, Yukari Uemura, Satoshi Kutsuna, Hidetoshi Nomoto, Kyoko Fujisawa, Maki Nagashima, Mari Terada,
and et al. 2022. "A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)" Life 12, no. 6: 856.
https://doi.org/10.3390/life12060856